Introduction to microperimetry and its use in analysis of geographic atrophy in age-related macular degeneration

Mostafa Hanout, Nicholas Horan, Diana V. Do

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Purpose of review This article discusses recent advances in the fundus-guided perimetry (microperimetry) and its utilization in evaluation and monitoring of patients with geographic atrophy. Recent findings Although best-corrected visual acuity has been gold standard in clinical practice for decades, it does not provide an entire assessment of visual function that determines daily activity and quality of life of a patient. Furthermore, psychophysical tests, including low-luminance visual acuity, reading speed, and contrast sensitivity, cannot be used to quantify retinal sensitivity or detect pattern of retinal dysfunction. Microperimetry provides a true evaluation of visual function by offering fundus-controlled testing through eye-tracking technology that allows for structural and functional correlation and test-retest reliability for the same test point. Furthermore, it enables precise assessment of location and stability of fixation. Recent research has shown microperimetry to be more representative of the macular function in macular diseases. Summary Microperimetry is currently the clinical investigation of choice to assess residual visual functions and functional vision in macular degenerative diseases, especially geographic atrophy. There is an increasing popularity to employ microperimetry in clinical trials investigating new treatments for geographic atrophy, as well as other macular degenerative diseases, as a reliable functional outcome measure.

Original languageEnglish (US)
Pages (from-to)149-156
Number of pages8
JournalCurrent Opinion in Ophthalmology
Volume26
Issue number3
DOIs
StatePublished - May 9 2015

Fingerprint

Geographic Atrophy
Macular Degeneration
Visual Acuity
Visual Field Tests
Contrast Sensitivity
Physiologic Monitoring
Reproducibility of Results
Reading
Quality of Life
Outcome Assessment (Health Care)
Clinical Trials
Technology
Research
Therapeutics

Keywords

  • fixation
  • geographic atrophy
  • microperimetry
  • preferred retinal locus
  • retinal sensitivity

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Introduction to microperimetry and its use in analysis of geographic atrophy in age-related macular degeneration. / Hanout, Mostafa; Horan, Nicholas; Do, Diana V.

In: Current Opinion in Ophthalmology, Vol. 26, No. 3, 09.05.2015, p. 149-156.

Research output: Contribution to journalArticle

@article{5c21dd0a95b84a81b3f7fdfd064bd48e,
title = "Introduction to microperimetry and its use in analysis of geographic atrophy in age-related macular degeneration",
abstract = "Purpose of review This article discusses recent advances in the fundus-guided perimetry (microperimetry) and its utilization in evaluation and monitoring of patients with geographic atrophy. Recent findings Although best-corrected visual acuity has been gold standard in clinical practice for decades, it does not provide an entire assessment of visual function that determines daily activity and quality of life of a patient. Furthermore, psychophysical tests, including low-luminance visual acuity, reading speed, and contrast sensitivity, cannot be used to quantify retinal sensitivity or detect pattern of retinal dysfunction. Microperimetry provides a true evaluation of visual function by offering fundus-controlled testing through eye-tracking technology that allows for structural and functional correlation and test-retest reliability for the same test point. Furthermore, it enables precise assessment of location and stability of fixation. Recent research has shown microperimetry to be more representative of the macular function in macular diseases. Summary Microperimetry is currently the clinical investigation of choice to assess residual visual functions and functional vision in macular degenerative diseases, especially geographic atrophy. There is an increasing popularity to employ microperimetry in clinical trials investigating new treatments for geographic atrophy, as well as other macular degenerative diseases, as a reliable functional outcome measure.",
keywords = "fixation, geographic atrophy, microperimetry, preferred retinal locus, retinal sensitivity",
author = "Mostafa Hanout and Nicholas Horan and Do, {Diana V.}",
year = "2015",
month = "5",
day = "9",
doi = "10.1097/ICU.0000000000000153",
language = "English (US)",
volume = "26",
pages = "149--156",
journal = "Current Opinion in Ophthalmology",
issn = "1040-8738",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Introduction to microperimetry and its use in analysis of geographic atrophy in age-related macular degeneration

AU - Hanout, Mostafa

AU - Horan, Nicholas

AU - Do, Diana V.

PY - 2015/5/9

Y1 - 2015/5/9

N2 - Purpose of review This article discusses recent advances in the fundus-guided perimetry (microperimetry) and its utilization in evaluation and monitoring of patients with geographic atrophy. Recent findings Although best-corrected visual acuity has been gold standard in clinical practice for decades, it does not provide an entire assessment of visual function that determines daily activity and quality of life of a patient. Furthermore, psychophysical tests, including low-luminance visual acuity, reading speed, and contrast sensitivity, cannot be used to quantify retinal sensitivity or detect pattern of retinal dysfunction. Microperimetry provides a true evaluation of visual function by offering fundus-controlled testing through eye-tracking technology that allows for structural and functional correlation and test-retest reliability for the same test point. Furthermore, it enables precise assessment of location and stability of fixation. Recent research has shown microperimetry to be more representative of the macular function in macular diseases. Summary Microperimetry is currently the clinical investigation of choice to assess residual visual functions and functional vision in macular degenerative diseases, especially geographic atrophy. There is an increasing popularity to employ microperimetry in clinical trials investigating new treatments for geographic atrophy, as well as other macular degenerative diseases, as a reliable functional outcome measure.

AB - Purpose of review This article discusses recent advances in the fundus-guided perimetry (microperimetry) and its utilization in evaluation and monitoring of patients with geographic atrophy. Recent findings Although best-corrected visual acuity has been gold standard in clinical practice for decades, it does not provide an entire assessment of visual function that determines daily activity and quality of life of a patient. Furthermore, psychophysical tests, including low-luminance visual acuity, reading speed, and contrast sensitivity, cannot be used to quantify retinal sensitivity or detect pattern of retinal dysfunction. Microperimetry provides a true evaluation of visual function by offering fundus-controlled testing through eye-tracking technology that allows for structural and functional correlation and test-retest reliability for the same test point. Furthermore, it enables precise assessment of location and stability of fixation. Recent research has shown microperimetry to be more representative of the macular function in macular diseases. Summary Microperimetry is currently the clinical investigation of choice to assess residual visual functions and functional vision in macular degenerative diseases, especially geographic atrophy. There is an increasing popularity to employ microperimetry in clinical trials investigating new treatments for geographic atrophy, as well as other macular degenerative diseases, as a reliable functional outcome measure.

KW - fixation

KW - geographic atrophy

KW - microperimetry

KW - preferred retinal locus

KW - retinal sensitivity

UR - http://www.scopus.com/inward/record.url?scp=84926680378&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84926680378&partnerID=8YFLogxK

U2 - 10.1097/ICU.0000000000000153

DO - 10.1097/ICU.0000000000000153

M3 - Article

VL - 26

SP - 149

EP - 156

JO - Current Opinion in Ophthalmology

JF - Current Opinion in Ophthalmology

SN - 1040-8738

IS - 3

ER -